Kevin L. Hagan to Serve as Next President/CEO of The PAN Foundation

Kevin L. Hagan succeeds Dan Klein, who is retiring after serving at the helm for seven years. Hagan’s appointment comes after a nationwide search by executive search firm Korn Ferry on behalf of the PAN Foundation Board of Directors.

“We are proud to name Kevin Hagan as the next president and CEO of the PAN Foundation,” said Board Chair Susan Rucker. “The Board of Directors agreed that he has the experience, acumen, and commitment to lead the organization at this pivotal moment as we advance our mission of serving patients in an expanded role and advocate for healthcare access and affordability.”

Kevin L. Hagan brings significant executive leadership experience at national and global nonprofit organizations, high-impact companies in the private sector, and within government. Hagan most recently served as CEO of Thrive Impact, a consulting firm he co-founded in 2018 that supports leadership teams at nonprofits, associations, and foundations in the areas of organizational strategy, leadership and governance, and revenue diversification.

Before founding Thrive Impact, Hagan led the growth and transformation for several highly respected national and international nonprofits, previously serving as CEO of the American Diabetes Association from 2015-2017, president and CEO of Feed the Children from 2012-2015, and chief operating officer of Good360 from 2009-2012. Prior to his nonprofit service, Hagan served as head of public affairs and communications for U.S. Foods, North America’s second-largest food distributor, where he also oversaw its philanthropic work. He joined U.S. Foods after more than a decade of national-level management roles at the United States Postal Service.

“Kevin brings decades of experience as an innovative leader and champion for tackling big challenges, such as finding a cure for diabetes and ending hunger in the U.S. and abroad. He understands the impact of the healthcare affordability crisis on people experiencing serious illnesses and, importantly, is dedicated to finding solutions,” said Board Vice Chair Deanna Banks. “As president and CEO, Kevin will build on the PAN Foundation’s significant accomplishments during the last seven years and pursue initiatives that address patients’ most pressing challenges.”

“Stepping into this role is a privilege and responsibility that I do not take lightly,” said Hagan. “Today, people with serious illnesses face tremendous barriers to getting treatment, making the PAN Foundation’s role as a charitable safety net more vital than ever. Serving as president and CEO, I am committed to making our vision of a nation where everyone can get medical treatment a reality.”

As president and CEO, Hagan will lead the PAN Foundation’s strategy and oversee its safety net programs and advocacy initiatives. To date, the organization has helped nearly one million patients pay for their out-of-pocket prescription medications and built a comprehensive advocacy platform to call for critical healthcare reforms.

Hot this week

Avery Dennison Medical Introduces Ipdated SilFoam Lite: Sustainability, MDR Certification & Performance Improvements

The newly enhanced SilFoam Lite delivers superior efficiency and reliability, bringing improved fluid handling capabilities and improved tack. These improvements make the product ideal for customers seeking quality, high-performance solutions in wound care notes Avery Dennison Medical.

Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life

Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMedâ„¢ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.